Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine for Postoperative Pain Control
NCT02353676Unknown
- Sponsor
- Cosmozone Dental Clinic
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in postoperative pain comparing Bupivacaine Group with Placebo Group (2 arms). Primary endpoint: Postoperative Analgesia Experienced by the Patients at 5 days. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02353676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353676.